Published in Immunity on December 15, 2011
The Role of Dietary Tryptophan on Aryl Hydrocarbon Receptor Activation (Aryl-IMMUNE) | NCT03059862
Reciprocal interactions of the intestinal microbiota and immune system. Nature (2012) 4.42
Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol (2013) 4.34
Innate lymphoid cells--how did we miss them? Nat Rev Immunol (2013) 3.62
Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells. Immunity (2013) 3.51
Control of pathogens and pathobionts by the gut microbiota. Nat Immunol (2013) 2.84
The biology of innate lymphoid cells. Nature (2015) 2.68
Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. Nature (2014) 2.26
Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence. Nature (2016) 2.23
Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science (2014) 2.20
CX₃CR1⁺ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med (2014) 2.09
Intestinal commensal microbes as immune modulators. Cell Host Microbe (2012) 2.07
Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions. Immunity (2014) 2.02
Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. Immunity (2013) 2.01
Development, differentiation, and diversity of innate lymphoid cells. Immunity (2014) 1.87
The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu Rev Pathol (2012) 1.80
Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity (2012) 1.73
Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat Med (2015) 1.63
Transcription Factor Bcl11b Controls Identity and Function of Mature Type 2 Innate Lymphoid Cells. Immunity (2015) 1.61
Distinct requirements for T-bet in gut innate lymphoid cells. J Exp Med (2012) 1.61
A mouse model links asthma susceptibility to prenatal exposure to diesel exhaust. J Allergy Clin Immunol (2013) 1.61
Interleukin-22: immunobiology and pathology. Annu Rev Immunol (2015) 1.60
Retinoic acid expression associates with enhanced IL-22 production by γδ T cells and innate lymphoid cells and attenuation of intestinal inflammation. J Exp Med (2013) 1.47
Epithelial-intrinsic IKKα expression regulates group 3 innate lymphoid cell responses and antibacterial immunity. J Exp Med (2015) 1.47
Feedback control of AHR signalling regulates intestinal immunity. Nature (2017) 1.45
The role of the immune system in governing host-microbe interactions in the intestine. Nat Immunol (2013) 1.41
Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens. J Exp Med (2014) 1.40
Gata3 drives development of RORγt+ group 3 innate lymphoid cells. J Exp Med (2014) 1.36
Antibiotics, microbiota, and immune defense. Trends Immunol (2012) 1.33
AhR sensing of bacterial pigments regulates antibacterial defence. Nature (2014) 1.30
Innate lymphoid cells: balancing immunity, inflammation, and tissue repair in the intestine. Cell Host Microbe (2012) 1.29
Small molecule inhibitors of RORγt: targeting Th17 cells and other applications. Eur J Immunol (2012) 1.24
Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis. J Clin Invest (2013) 1.23
Transcriptional regulation of innate lymphoid cell fate. Nat Rev Immunol (2015) 1.21
Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat Immunol (2016) 1.21
Regulation of the immune system by the resident intestinal bacteria. Gastroenterology (2014) 1.19
Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection. Immunity (2014) 1.14
A network of high-mobility group box transcription factors programs innate interleukin-17 production. Immunity (2013) 1.12
Dietary influences on intestinal immunity. Nat Rev Immunol (2012) 1.11
Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation. J Exp Med (2015) 1.11
Exposure to atmospheric particulate matter enhances Th17 polarization through the aryl hydrocarbon receptor. PLoS One (2013) 1.06
IL-21 induces IL-22 production in CD4+ T cells. Nat Commun (2014) 1.05
Host-microbiota interactions in inflammatory bowel disease. Gut Microbes (2012) 1.05
Recognition strategies of group 3 innate lymphoid cells. Front Immunol (2014) 1.03
AHR and the Transcriptional Regulation of Type-17/22 ILC. Front Immunol (2012) 0.99
Immunoregulatory molecules are master regulators of inflammation during the immune response. FEBS Lett (2012) 0.98
IL-22 in tissue-protective therapy. Br J Pharmacol (2013) 0.98
Healing of intestinal inflammation by IL-22. Inflamm Bowel Dis (2012) 0.97
Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage. J Immunol (2015) 0.97
IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis. PLoS Pathog (2013) 0.96
The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells. Cell Rep (2014) 0.94
IL-22 fate reporter reveals origin and control of IL-22 production in homeostasis and infection. J Immunol (2014) 0.94
Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research. Front Immunol (2014) 0.93
Transcriptional and epigenetic networks of helper T and innate lymphoid cells. Immunol Rev (2014) 0.93
The interplay between the gut microbiota and the immune system. Gut Microbes (2014) 0.93
Downregulation of microRNA-107 in intestinal CD11c(+) myeloid cells in response to microbiota and proinflammatory cytokines increases IL-23p19 expression. Eur J Immunol (2014) 0.91
Runx3 specifies lineage commitment of innate lymphoid cells. Nat Immunol (2015) 0.91
MicroRNA-375 regulation of thymic stromal lymphopoietin by diesel exhaust particles and ambient particulate matter in human bronchial epithelial cells. J Immunol (2013) 0.90
The unusual suspects--innate lymphoid cells as novel therapeutic targets in IBD. Nat Rev Gastroenterol Hepatol (2015) 0.90
Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 production. PLoS One (2014) 0.90
The Aryl Hydrocarbon Receptor: A Key Bridging Molecule of External and Internal Chemical Signals. Environ Sci Technol (2015) 0.90
Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles. Sci Rep (2015) 0.89
The aryl hydrocarbon receptor promotes IL-10 production by NK cells. J Immunol (2014) 0.89
SU5416, a VEGF receptor inhibitor and ligand of the AHR, represents a new alternative for immunomodulation. PLoS One (2012) 0.89
Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through ID2-Dependent Regulation of the Microbiota. Immunity (2015) 0.89
Understanding and modulating mammalian-microbial communication for improved human health. Annu Rev Pharmacol Toxicol (2013) 0.89
Role of the aryl hydrocarbon receptor (AhR) in lung inflammation. Semin Immunopathol (2013) 0.88
Innate lymphoid cells in the defense against infections. Eur J Microbiol Immunol (Bp) (2013) 0.88
Aryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation. Semin Immunopathol (2013) 0.87
Beyond NK cells: the expanding universe of innate lymphoid cells. Front Immunol (2014) 0.87
The aryl hydrocarbon receptor: a novel target for immunomodulation in organ transplantation. Transplantation (2013) 0.86
Aryl hydrocarbon receptor: Linking environment to immunity. Semin Immunol (2015) 0.86
Development of innate lymphoid cells. Nat Immunol (2016) 0.84
Group 3 innate lymphoid cells continuously require the transcription factor GATA-3 after commitment. Nat Immunol (2015) 0.84
Butyrate produced by commensal bacteria potentiates phorbol esters induced AP-1 response in human intestinal epithelial cells. PLoS One (2012) 0.84
Role of the Aryl Hydrocarbon Receptor in Controlling Maintenance and Functional Programs of RORγt(+) Innate Lymphoid Cells and Intraepithelial Lymphocytes. Front Immunol (2012) 0.84
Toward understanding the role of aryl hydrocarbon receptor in the immune system: current progress and future trends. Biomed Res Int (2014) 0.84
An in vitro model of innate lymphoid cell function and differentiation. Mucosal Immunol (2014) 0.84
Tissue-specific effector functions of innate lymphoid cells. Immunology (2013) 0.84
Benzimidazoisoquinolines: a new class of rapidly metabolized aryl hydrocarbon receptor (AhR) ligands that induce AhR-dependent Tregs and prevent murine graft-versus-host disease. PLoS One (2014) 0.83
Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation. Drug Metab Dispos (2015) 0.83
Diversity, function, and transcriptional regulation of gut innate lymphocytes. Front Immunol (2013) 0.83
Maintenance of Immune Homeostasis through ILC/T Cell Interactions. Front Immunol (2015) 0.83
AHR Function in Lymphocytes: Emerging Concepts. Trends Immunol (2015) 0.82
Innate lymphoid cell function in the context of adaptive immunity. Nat Immunol (2016) 0.82
The interplay between the intestinal microbiota and the immune system. Clin Res Hepatol Gastroenterol (2014) 0.81
New insights into gastrointestinal anthrax infection. Trends Mol Med (2014) 0.81
T cell contamination in flow cytometry gating approaches for analysis of innate lymphoid cells. PLoS One (2014) 0.81
DOCK8 regulates protective immunity by controlling the function and survival of RORγt+ ILCs. Nat Commun (2014) 0.81
The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism. Semin Immunopathol (2014) 0.81
Interleukin-22 Signaling in the Regulation of Intestinal Health and Disease. Front Cell Dev Biol (2016) 0.80
Influence of nutrient-derived metabolites on lymphocyte immunity. Nat Med (2015) 0.80
The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease. Mol Neurobiol (2016) 0.80
The aryl hydrocarbon receptor in innate T cell immunity. Semin Immunopathol (2013) 0.79
The Group 3 Innate Lymphoid Cell Defect in Aryl Hydrocarbon Receptor Deficient Mice Is Associated with T Cell Hyperactivation during Intestinal Infection. PLoS One (2015) 0.79
Microbial-immune cross-talk and regulation of the immune system. Immunology (2013) 0.79
Breast Milk and Solid Food Shaping Intestinal Immunity. Front Immunol (2015) 0.79
Restriction of IL-22-producing T cell responses and differential regulation of regulatory T cell compartments by zinc finger transcription factor Ikaros. J Immunol (2014) 0.79
Innate lymphoid cells, possible interaction with microbiota. Semin Immunopathol (2014) 0.79
New insights into the aryl hydrocarbon receptor as a modulator of host responses to infection. Semin Immunopathol (2013) 0.78
Balancing intestinal and systemic inflammation through cell type-specific expression of the aryl hydrocarbon receptor repressor. Sci Rep (2016) 0.78
The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell (2006) 33.94
Transforming growth factor-beta induces development of the T(H)17 lineage. Nature (2006) 25.91
IL-17 and Th17 Cells. Annu Rev Immunol (2009) 23.02
Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell (2009) 20.29
TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature (2008) 14.26
Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol (2007) 12.72
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med (2008) 12.68
Phenotypic and functional features of human Th17 cells. J Exp Med (2007) 11.33
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature (2008) 10.15
Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature (2008) 9.32
IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med (2008) 9.05
The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity (2009) 8.95
An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol (2003) 8.23
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature (2008) 8.22
Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol (2010) 6.88
Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity (2008) 6.49
Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature (2010) 6.44
Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature (1999) 6.23
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest (2008) 6.17
Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity (2009) 6.05
The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol (2010) 6.02
RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat Immunol (2008) 5.91
Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med (2007) 5.58
Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol (2011) 5.05
Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med (2008) 4.95
Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol (2008) 4.94
Organogenesis of lymphoid tissues. Nat Rev Immunol (2003) 4.53
Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature (2008) 4.42
CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity (2010) 4.19
Lineage relationship analysis of RORgammat+ innate lymphoid cells. Science (2010) 4.12
The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat Immunol (2010) 4.06
Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity (1996) 3.91
The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol (2007) 3.68
Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes. Immunity (2010) 3.59
Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J Exp Med (2007) 3.36
Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc Natl Acad Sci U S A (2008) 3.34
CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity (2000) 3.28
Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity (2009) 3.02
Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nat Immunol (2010) 3.00
IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med (2011) 2.74
Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells. J Exp Med (2010) 2.64
Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge. Cell Host Microbe (2011) 2.46
The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology (2009) 2.31
Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J Exp Med (2009) 2.02
Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages. Nat Immunol (2010) 1.97
Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans. Eur J Immunol (1999) 1.86
Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells. Immunity (2007) 1.79
IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium. Nat Immunol (2011) 1.78
The dual nature of T(H)17 cells: shifting the focus to function. Nat Immunol (2010) 1.78
Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor. Arch Biochem Biophys (2005) 1.76
Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt- lymphoid cells. EMBO J (2011) 1.74
Lymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection. Immunity (2010) 1.50
Definition of a dioxin receptor mutant that is a constitutive activator of transcription: delineation of overlapping repression and ligand binding functions within the PAS domain. J Biol Chem (2001) 1.47
Regulating the regulator: factors that control levels and activity of the aryl hydrocarbon receptor. Biochem Pharmacol (2006) 1.34
Nramp1 expression by dendritic cells modulates inflammatory responses during Salmonella Typhimurium infection. Cell Microbiol (2008) 1.13
D-amino acid oxidase generates agonists of the aryl hydrocarbon receptor from D-tryptophan. Chem Res Toxicol (2009) 1.01
Production of Ah receptor ligands in rat fecal suspensions containing tryptophan or indole-3-carbinol. Nutr Cancer (1991) 0.94
The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell (2006) 33.94
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet (2011) 5.73
Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol (2013) 5.43
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood (2009) 5.21
Priming of naive T cells inside tumors leads to eradication of established tumors. Nat Immunol (2004) 3.95
Transcriptional regulation of Th17 cell differentiation. Semin Immunol (2007) 3.86
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma. Nat Genet (2011) 3.66
The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity. Cancer Cell (2010) 3.52
Adaptive immune cells temper initial innate responses. Nat Med (2007) 3.37
Induced sensitization of tumor stroma leads to eradication of established cancer by T cells. J Exp Med (2007) 3.15
Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J Clin Invest (2008) 3.13
Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Invest (2014) 3.06
Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med (2005) 3.01
Recognition of host immune activation by Pseudomonas aeruginosa. Science (2005) 2.84
Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer. Sci Transl Med (2012) 2.62
The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity. Cancer Res (2011) 2.60
Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge. Cell Host Microbe (2011) 2.46
Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol (2006) 2.44
CD95 promotes tumour growth. Nature (2010) 2.42
Mental disorders and suicide among young rural Chinese: a case-control psychological autopsy study. Am J Psychiatry (2010) 2.23
Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease. Nat Med (2002) 2.23
Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection. J Exp Med (2010) 2.22
Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice. J Exp Med (2009) 2.12
Lymphotoxin beta receptor-dependent control of lipid homeostasis. Science (2007) 2.06
Targeting the intracellular WT1 oncogene product with a therapeutic human antibody. Sci Transl Med (2013) 2.03
Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice. Gastroenterology (2012) 2.01
Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. Immunity (2013) 2.01
Clinical experiences with anti-CD137 and anti-PD1 therapeutic antibodies. Semin Oncol (2010) 2.00
Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo. J Clin Invest (2006) 2.00
Lymphotoxin regulates commensal responses to enable diet-induced obesity. Nat Immunol (2012) 1.99
Tumor masses support naive T cell infiltration, activation, and differentiation into effectors. J Exp Med (2010) 1.97
B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. J Exp Med (2003) 1.92
Generation of an inbred miniature pig model of retinitis pigmentosa. Invest Ophthalmol Vis Sci (2012) 1.87
Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology (2008) 1.84
CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J Exp Med (2011) 1.82
The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. J Clin Invest (2005) 1.82
Lymphotoxin pathway directs thymic Aire expression. Nat Immunol (2003) 1.79
Metal oxide hollow nanostructures for lithium-ion batteries. Adv Mater (2012) 1.77
Systemic spread and propagation of a plant-pathogenic virus in European honeybees, Apis mellifera. MBio (2014) 1.71
Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J Clin Invest (2004) 1.71
B cell maintenance of subcapsular sinus macrophages protects against a fatal viral infection independent of adaptive immunity. Immunity (2012) 1.70
LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms. Gastroenterology (2007) 1.70
Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control. J Exp Med (2003) 1.68
Zinc-finger protein 545 is a novel tumour suppressor that acts by inhibiting ribosomal RNA transcription in gastric cancer. Gut (2012) 1.67
The human BCL6 transgene promotes the development of lymphomas in the mouse. Proc Natl Acad Sci U S A (2004) 1.63
B and T lymphocyte attenuator regulates CD8+ T cell-intrinsic homeostasis and memory cell generation. Nat Immunol (2007) 1.61
Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases. J Immunol (2007) 1.60
Type I interferon response and innate immune sensing of cancer. Trends Immunol (2012) 1.59
C/EBPbeta regulation in lipopolysaccharide-stimulated macrophages. Mol Cell Biol (2003) 1.58
Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. J Clin Invest (2006) 1.57
The role of stroma in immune recognition and destruction of well-established solid tumors. Curr Opin Immunol (2006) 1.56
Tumor-infiltrating T lymphocytes: friends or foes? Lab Invest (2006) 1.56
Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature (2003) 1.51
Lymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection. Immunity (2010) 1.50
Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells. J Exp Med (2003) 1.49
A c-Rel subdomain responsible for enhanced DNA-binding affinity and selective gene activation. Genes Dev (2005) 1.45
Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis. J Immunol (2002) 1.45
Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing. J Immunol (2013) 1.44
OX40 signaling favors the induction of T(H)9 cells and airway inflammation. Nat Immunol (2012) 1.43
NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors. Blood (2005) 1.43
Recruitment and activation of naive T cells in the islets by lymphotoxin beta receptor-dependent tertiary lymphoid structure. Immunity (2006) 1.40
Equilibrium between host and cancer caused by effector T cells killing tumor stroma. Cancer Res (2008) 1.39
Retracted Impact of guidewire selection and operator expertise on radiation exposure in transradial angiography. J Cardiothorac Surg (2014) 1.39
Signaling via LTbetaR on the lamina propria stromal cells of the gut is required for IgA production. Nat Immunol (2002) 1.36
Hyper innate responses in neonates lead to increased morbidity and mortality after infection. Proc Natl Acad Sci U S A (2008) 1.33
Rheb1 is required for mTORC1 and myelination in postnatal brain development. Dev Cell (2011) 1.31
Tumor necrosis factor family members and inflammatory bowel disease. Immunol Rev (2005) 1.29
NF-kappaB2 is required for the establishment of central tolerance through an Aire-dependent pathway. J Clin Invest (2006) 1.29
Targeting CD137 enhances the efficacy of cetuximab. J Clin Invest (2014) 1.29
Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy. J Clin Invest (2004) 1.28
Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues. J Clin Invest (2003) 1.27
Comparison of nonlinear dynamic methods and perturbation methods for voice analysis. J Acoust Soc Am (2005) 1.25
Cetuximab-mediated tumor regression depends on innate and adaptive immune responses. Mol Ther (2012) 1.24
TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. Gastroenterology (2013) 1.24
A Novel YY1-miR-1 regulatory circuit in skeletal myogenesis revealed by genome-wide prediction of YY1-miRNA network. PLoS One (2012) 1.23
Gadd45beta promotes hepatocyte survival during liver regeneration in mice by modulating JNK signaling. J Clin Invest (2008) 1.23
The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin receptor signaling to achieve homeostasis of dendritic cells. J Immunol (2008) 1.23
Nonlinear dynamic analysis of voices before and after surgical excision of vocal polyps. J Acoust Soc Am (2004) 1.22
OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3. Nature (2013) 1.21
B and T lymphocyte attenuator tempers early infection immunity. J Immunol (2009) 1.18
The role of tumor-associated macrophages in breast cancer progression (review). Int J Oncol (2013) 1.16
Negative regulation of CD40-mediated B cell responses by E3 ubiquitin ligase Casitas-B-lineage lymphoma protein-B. J Immunol (2007) 1.16
A data encryption solution for mobile health apps in cooperation environments. J Med Internet Res (2013) 1.15
MicroRNA-10b promotes migration and invasion through CADM1 in human hepatocellular carcinoma cells. Tumour Biol (2012) 1.15
Comparative mRNA and microRNA expression profiling of three genitourinary cancers reveals common hallmarks and cancer-specific molecular events. PLoS One (2011) 1.15
Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma. Biochem Biophys Res Commun (2012) 1.14
The critical role of LIGHT in promoting intestinal inflammation and Crohn's disease. J Immunol (2005) 1.14
Genome-wide survey by ChIP-seq reveals YY1 regulation of lincRNAs in skeletal myogenesis. EMBO J (2013) 1.12
Dynamic light scattering as a relative tool for assessing the molecular integrity and stability of monoclonal antibodies. Biotechnol Genet Eng Rev (2007) 1.12
Stimulating lymphotoxin beta receptor on the dendritic cells is critical for their homeostasis and expansion. J Immunol (2005) 1.10
Contribution of the lymphotoxin beta receptor to liver regeneration. J Immunol (2005) 1.10
Developmental pathway of CD4+CD8- medullary thymocytes during mouse ontogeny and its defect in Aire-/- mice. Proc Natl Acad Sci U S A (2007) 1.08
Suppression of inflammation and acute lung injury by Miz1 via repression of C/EBP-δ. Nat Immunol (2013) 1.08
Lymphotoxin-beta receptor-dependent genes in lymph node and follicular dendritic cell transcriptomes. J Immunol (2005) 1.07
Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis. Mol Ther (2012) 1.07